DelveInsight's“ Obesity Pipeline Insigh t 2025 ” report provides comprehensive insights about 80+ companies and 100+ pipeline ...

As the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity ...

The presentation included new PK and PD data showing that 90mg of avexitide daily maintained continuous pharmacologic ...

People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

CoQ10 may interact with certain medications, causing side effects or making them less effective. Find out if you shouldn't ...

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...

Beverly Hills MD®, founded by renowned cosmetic surgeons Dr. John Layke and Dr. Payman Danielpour, is proud to announce the ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

In 2022, over 1 billion people were affected by obesity, driving innovation in therapeutic advancements. Emerging treatments focus on appetite contro ...

S. Daniel Abraham, a onetime traveling salesman who started a line of weight-loss products led by the popular Slim-Fast diet drinks and who later used his fortune as a major Democratic political donor ...

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx Pharmaceuticals announced new exploratory analyses from its Phase 2 PREVENT and ...